Safety Evaluation of ExAblate MRgFUS for Prostate Cancer

NCT00811265 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-03-08

No results posted yet for this study

Summary

Evaluate the safety, compatibility and imaging quality of the ExAblate MRgFUS system.

Conditions

Interventions

DEVICE

ExAblate MRgFUS for prostate cancer

Simulated use of ExAblate MRgFUS system

Sponsors & Collaborators

  • InSightec

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00811265 on ClinicalTrials.gov